Coagulation and fibrinolysis

Scandinavian Journal of Gastroenterology. Supplement
I M Nilsson

Abstract

The two final phases in the haemostatic process, plasma coagulation with the formation of a fibrin clot, and fibrinolysis leading to the dissolution of fibrin clots, are reviewed. Coagulation may be initiated either by reactions occurring between components of the blood alone, the intrinsic pathway, or by reactions which also involve tissue components, termed the extrinsic pathway. In the diagnosis of coagulation disorders, it is convenient to divide the intrinsic pathway into three phases. In phase 1, resulting in the activation of factor (f) X, are involved f XII, XI, VIII and IX, platelet phospholipids, and calcium. In phase 2, prothrombin is converted to thrombin by f Xa in conjunction with f V, phospholipids, calcium. In phase 3, thrombin converts fibrinogen to fibrin, which is then stabilized by f XIII. Antithrombin III is the most important inhibitor. The key component in fibrinolysis is plasminogen, which under the influence of various activators is converted to plasmin. Plasmin is a serine protease and its main in vivo target is fibrin. Alpha 2-antiplasmin and a fast-acting inhibitor of tissue plasminogen activator are the most important inhibitors.

References

Sep 29, 1979·Biochimica Et Biophysica Acta·D C RijkenJ Welbergen
Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D J Loskutoff, T E Edgington
Jan 1, 1979·Progress in Cardiovascular Diseases·N Aoki
Jan 1, 1977·Annual Review of Biochemistry·J Stenflo, J W Suttie
Jul 1, 1978·The Journal of Clinical Investigation·G H GoldsmithO S Ratnoff
Aug 12, 1976·Biochimica Et Biophysica Acta·L HolmbergB Astedt
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·Y Nemerson, M P Esnouf
Jun 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·R Chen, R F Doolittle
Apr 19, 1968·Biochemical and Biophysical Research Communications·L LorandS Tokura
Apr 1, 1984·Seminars in Thrombosis and Hemostasis·C T Esmon, N L Esmon
Apr 1, 1984·Seminars in Thrombosis and Hemostasis·J H Griffin
Apr 1, 1984·Seminars in Thrombosis and Hemostasis·J Stenflo
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D J LoskutoffD Lawrence
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Jan 1, 1982·Acta Obstetricia Et Gynecologica Scandinavica·B L PerssonI M Nilsson
Sep 18, 1964·Science·E W DAVIE, O D RATNOFF

❮ Previous
Next ❯

Citations

Nov 1, 1989·Archives of Gerontology and Geriatrics·K HagerD Platt
Nov 5, 1999·Journal of Pediatric and Adolescent Gynecology·M H Ellis, Y Beyth
Jan 24, 2003·American Journal of Respiratory Cell and Molecular Biology·Leslie R BerryAnthony K C Chan
Jan 1, 1997·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·D MoopanarE Gouws
Oct 30, 2014·Journal of Veterinary Emergency and Critical Care·Susanna S NagelAmelia Goddard
Sep 30, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Joseph L NatesMarie-Françoise Doursout
Oct 26, 2005·Journal of Dental Research·G Gómez-MorenoC Scully

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Essays in Biochemistry
Peter N Walsh, Syed S Ahmad
Handbook of Experimental Pharmacology
J ArnoutH R Lijnen
© 2021 Meta ULC. All rights reserved